Trinity Biotech

Trinity Biotech plc is a publicly traded company specializing in the development, manufacture, and marketing of clinical diagnostic products. The company primarily serves healthcare providers and laboratories by offering diagnostic test kits for various autoimmune disorders, including Antiphospholipid syndrome, Coeliac disease, Systemic Rheumatoid diseases, Vasculitis, Thyroid disease, and Liver disease. Operating in the global healthcare market, Trinity Biotech has facilities in Europe and America, and its products are available in more than 110 countries. The business model focuses on the sale of diagnostic kits and raw materials to the life sciences industry, generating revenue through direct sales and distribution partnerships. The company is listed on the NASDAQ exchange, which adds a layer of financial credibility and transparency.

Keywords: clinical diagnostics, autoimmune disorders, test kits, healthcare, laboratories, global market, NASDAQ, life sciences, raw materials, Europe America.